v3.25.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Retained Earnings
Accumulated Other Comprehensive Income
Total Common Equity
Noncontrolling Interests in Subsidiaries
Balance at Oct. 31, 2023 $ 18,476 $ 74 $ 32,074 $ (8,968) $ 1,336 $ 24,516 $ (6,040)
Balance (in Shares) at Oct. 31, 2023   7,450          
Stock based compensation expense 1 1 1
Distributions to noncontrolling interests in subsidiaries (180) (180)
Net income (loss) (666)     (512)   (512) (154)
Dividends declared (372) (372) (372)
Net unrealized loss on interest rate swap contracts (530) (530) (530)
Net unrealized gain on investment in U.S. Treasury securities available-for-sale (7) (7) (7)
Balance at Jan. 31, 2024 16,722 $ 74 32,075 (9,852) 799 23,096 (6,374)
Balance (in Shares) at Jan. 31, 2024   7,450          
Balance at Oct. 31, 2023 18,476 $ 74 32,074 (8,968) 1,336 24,516 (6,040)
Balance (in Shares) at Oct. 31, 2023   7,450          
Net income (loss) (267)            
Net unrealized gain on investment in U.S. Treasury securities available-for-sale (20)            
Balance at Apr. 30, 2024 16,533 $ 75 32,215 (9,692) 1,043 23,641 (7,108)
Balance (in Shares) at Apr. 30, 2024   7,458          
Balance at Jan. 31, 2024 16,722 $ 74 32,075 (9,852) 799 23,096 (6,374)
Balance (in Shares) at Jan. 31, 2024   7,450          
Stock awards granted to directors 141 $ 1 140     141
Stock awards granted to directors (in Shares)   8          
Distributions to noncontrolling interests in subsidiaries (600)         (600)
Net income (loss) 399     533   533 (134)
Dividends declared (373)     (373)   (373)
Net unrealized loss on interest rate swap contracts 257       257 257
Net unrealized gain on investment in U.S. Treasury securities available-for-sale (13)       (13) (13)
Balance at Apr. 30, 2024 16,533 $ 75 32,215 (9,692) 1,043 23,641 (7,108)
Balance (in Shares) at Apr. 30, 2024   7,458          
Balance at Oct. 31, 2024 26,184 $ 75 32,253 541 494 33,363 (7,179)
Balance (in Shares) at Oct. 31, 2024   7,463          
Distributions to noncontrolling interests in subsidiaries (440) (440)
Net income (loss) 501 614 614 (113)
Dividends declared (597) (597) (597)
Net unrealized loss on interest rate swap contracts (42) (42) (42)
Net unrealized gain on investment in U.S. Treasury securities available-for-sale 13       13 13
Balance at Jan. 31, 2025 25,619 $ 75 32,253 558 465 33,351 (7,732)
Balance (in Shares) at Jan. 31, 2025   7,463          
Balance at Oct. 31, 2024 26,184 $ 75 32,253 541 494 33,363 (7,179)
Balance (in Shares) at Oct. 31, 2024   7,463          
Net income (loss) 1,282            
Net unrealized gain on investment in U.S. Treasury securities available-for-sale (6)            
Balance at Apr. 30, 2025 25,494 $ 75 32,393 854 219 33,541 (8,047)
Balance (in Shares) at Apr. 30, 2025   7,471          
Balance at Jan. 31, 2025 25,619 $ 75 32,253 558 465 33,351 (7,732)
Balance (in Shares) at Jan. 31, 2025   7,463          
Stock awards granted to directors 140 140     140
Stock awards granted to directors (in Shares)   8          
Distributions to noncontrolling interests in subsidiaries (202)         (202)
Net income (loss) 781     894   894 (113)
Dividends declared (598)     (598)   (598)
Net unrealized loss on interest rate swap contracts (227)       (227) (227)
Net unrealized gain on investment in U.S. Treasury securities available-for-sale (19)       (19) (19)
Balance at Apr. 30, 2025 $ 25,494 $ 75 $ 32,393 $ 854 $ 219 $ 33,541 $ (8,047)
Balance (in Shares) at Apr. 30, 2025   7,471